You are here:

Forthcoming Submissions:

PACE medicines

Name Manufacturer Submission Type Patient Group Submission Deadline SMC Meeting Date Advice Due

Non-PACE medicines

Name Manufacturer Submission Type Patient Group Submission Deadline SMC Meeting Date Advice Due
adalimumab (Humira) AbbVie Ltd Abbreviated Submission N/A 2/05/2017 12/06/2017
ixekizumab (Taltz) Eli Lilly and Company Ltd Full submission 6/02/2017 7/03/2017 10/04/2017

Medicines with advice withheld pending product availability

Name Manufacturer Submission Type Patient Group Submission Deadline SMC Meeting Date Advice Due

Back